Horizon Therapeutics Public Ltd Co

VOLORIDGE INVESTMENT MANAGEMENT, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

79,737

Value ($000)

8,201

Weight

0.0%

2019 Q4 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	8,201	0.0%	79,737	6/30/2023
2023 Q1	5/15/2023	12,193	0.1%	111,720	3/31/2023
2022 Q4	2/14/2023	1,744	0.0%	15,322	12/31/2022
2022 Q3	11/14/2022	22,904	0.1%	370,068	9/30/2022
2022 Q2	8/15/2022	5,480	0.0%	68,701	6/30/2022
2022 Q1	5/16/2022	10,278	0.1%	97,695	3/31/2022
2021 Q3	11/15/2021	2,583	0.0%	23,578	9/30/2021
2021 Q2	8/16/2021	5,632	0.0%	60,141	6/30/2021
2020 Q4	2/16/2021	12,461	0.1%	170,355	12/31/2020
2020 Q3	11/16/2020	24,708	0.2%	318,080	9/30/2020
2020 Q2	8/14/2020	25,278	0.3%	454,808	6/30/2020
2020 Q1	5/15/2020	6,802	0.2%	229,641	3/31/2020
2019 Q4	2/14/2020	6,841	0.1%	188,989	12/31/2019